Characterization of rodent models of HIV-gp120 and anti-retroviral-associated neuropathic pain.
Characterization of rodent models of HIV-gp120 and anti-retroviral-associated neuropathic pain.
复制标题
DOI：
10.1093/brain/awm195
复制
发表时间：
2007-10
期刊：
影响因子：
--
通讯作者：
Rice AS
中科院分区：
文献类型：
--
作者：
Wallace VC;Blackbeard J;Segerdahl AR;Hasnie F;Pheby T;McMahon SB;Rice AS
A distal symmetrical sensory peripheral neuropathy is frequently observed in people living with Human Immunodeficiency Virus Type 1 (HIV-1). This neuropathy can be associated with viral infection alone, probably involving a role for the envelope glycoprotein gp120; or a drug-induced toxic neuropathy associated with the use of nucleoside analogue reverse transcriptase inhibitors as a component of highly active anti-retroviral therapy. In order to elucidate the mechanisms underlying drug-induced neuropathy in the context of HIV infection, we have characterized pathological events in the peripheral and central nervous system following systemic treatment with the anti-retroviral agent, ddC (Zalcitabine) with or without the concomitant delivery of HIV-gp120 to the rat sciatic nerve (gp120+ddC). Systemic ddC treatment alone is associated with a persistent mechanical hypersensitivity (33% decrease in limb withdrawal threshold) that when combined with perineural HIV-gp120 is exacerbated (48% decrease in threshold) and both treatments result in thigmotactic (anxiety-like) behaviour. Immunohistochemical studies revealed little ddC-associated alteration in DRG phenotype, as compared with known changes following perineural HIV-gp120. However, the chemokine CCL2 is significantly expressed in the DRG of rats treated with perineural HIV-gp120 and/or ddC and there is a reduction in intraepidermal nerve fibre density, comparable to that seen in herpes zoster infection. Moreover, a spinal gliosis is apparent at times of peak behavioural sensitivity that is exacerbated in gp120+ddC as compared to either treatment alone. Treatment with the microglial inhibitor, minocycline, is associated with delayed onset of hypersensitivity to mechanical stimuli in the gp120+ddC model and reversal of some measures of thigmotaxis. Finally, the hypersensitivity to mechanical stimuli was sensitive to systemic treatment with gabapentin, morphine and the cannabinoid WIN 55,212-2, but not with amitriptyline. These data suggests that both neuropathic pain models display many features of HIV- and anti-retroviral-related peripheral neuropathy. They therefore merit further investigation for the elucidation of underlying mechanisms and may prove useful for preclinical assessment of drugs for the treatment of HIV-related peripheral neuropathic pain.
登录
查看更多内容
影响因子：
5.7
作者：
Abdi, S;Lee, DH;Chung, JM
通讯作者：
Chung, JM
影响因子：
7.4
作者：
Garry, EM;Delaney, A;Fleetwood-Walker, SM
通讯作者：
Fleetwood-Walker, SM
影响因子：
3
作者：
Gazzard, B.
通讯作者：
Gazzard, B.
影响因子：
11.2
作者：
APOSTOLSKI, S;MCALARNEY, T;LATOV, N
通讯作者：
LATOV, N
影响因子：
9.9
作者：
Abrams, D. I.;Jay, C. A.;Petersen, K. L.
通讯作者：
Petersen, K. L.